➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Moodys
Colorcon
Mallinckrodt
Medtronic

Last Updated: May 6, 2021

DrugPatentWatch Database Preview

TRIAMCINOLONE ACETONIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Triamcinolone Acetonide, and what generic alternatives are available?

Triamcinolone Acetonide is a drug marketed by Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Cosette, Fougera Pharms, Glenmark Pharms Ltd, Lupin, Macleods Pharms Ltd, Morton Grove, Mylan, Perrigo New York, Pharmaderm, Pharmafair, Saptalis Pharms, Strides Pharma, Taro, Taro Pharm Inds Ltd, Teligent, Topiderm, Amneal, Parnell, Sandoz Inc, Teva Pharms Usa, Watson Labs, Akorn, Quagen, Wockhardt Bio Ag, Cintex Svcs, Encube, Glenmark Pharms, Novel Labs Inc, Perrigo Israel, Lyne, Perrigo Uk Finco, Rising, and Cmp Pharma Inc. and is included in eighty-seven NDAs.

The generic ingredient in TRIAMCINOLONE ACETONIDE is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-five suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Drug patent expirations by year for TRIAMCINOLONE ACETONIDE
Drug Prices for TRIAMCINOLONE ACETONIDE

See drug prices for TRIAMCINOLONE ACETONIDE

Drug Sales Revenue Trends for TRIAMCINOLONE ACETONIDE

See drug sales revenues for TRIAMCINOLONE ACETONIDE

Recent Clinical Trials for TRIAMCINOLONE ACETONIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ottawa Hospital Research InstitutePhase 4
University of FloridaPhase 4
B.P. Koirala Institute of Health SciencesN/A

See all TRIAMCINOLONE ACETONIDE clinical trials

Pharmacology for TRIAMCINOLONE ACETONIDE
Medical Subject Heading (MeSH) Categories for TRIAMCINOLONE ACETONIDE

US Patents and Regulatory Information for TRIAMCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 208925-001 Oct 6, 2017 AT RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Taro Pharm Inds Ltd TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 040037-001 Sep 30, 1994 AT RX No No   Get Started for $10   Get Started for $10   Get Started for $10
Taro TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 086275-001 Approved Prior to Jan 1, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Pharmafair TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 087922-001 Aug 10, 1982 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
Mylan TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 011600-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Get Started for $10   Get Started for $10   Get Started for $10
Sandoz Inc TRIAMCINOLONE ACETONIDE triamcinolone acetonide INJECTABLE;INJECTION 090166-001 May 27, 2009 DISCN No No   Get Started for $10   Get Started for $10   Get Started for $10
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Express Scripts
McKinsey
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.